Mangrove Partners Axsome Therapeutics, Inc. Transaction History

Mangrove Partners

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $385,580 - $829,158	17,736 Added 9.76%	199,431 $7.64 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $4.31 Million - $7.52 Million	181,695 New	181,695 $7.52 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.